ANDRADE ROBERT (CHIEF FINANCIAL OFFICER) sold 25.6% of their position (75K shares) of FENNEC PHARMACEUTICALS INC. on the open market
Open‑market sale worth $883.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/28/2026ACC: 0001468308-26-000028
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
-75K
Net shares
Net seller
$883.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
21.93K acquired · 96.93K disposed
Non-Derivative Transactions2
Common shares
Direct
Shares
−75K
Price / share
$11.78
Trade value
$883.50K
% of position
25.6%
8/27/2026
292.68K→217.68K
Common shares
Direct
Shares
+21.93K
Price / share
$5.10
Trade value
$111.83K
% of position
10.1%
8/28/2026
217.68K→239.60K
Total
Net shares
−53.07K
Net value
-$771.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common shares Direct | 8/27/2026 | S · Sale | −75K | $11.78 | $883.50K | 25.6% | 292.68K | 217.68K |
| Common shares Direct | 8/28/2026 | M · Option Exercise | +21.93K | $5.10 | $111.83K | 10.1% | 217.68K | 239.60K |
| Total | −53.07K | -$771.67K | ||||||
Derivative Transactions1
Stock Options
Direct
Converts to
Common Shares
21.93K shares
Shares
−21.93K
Strike price
5.10
Held after
779.33K
Exercisable
—
8/28/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options Direct | Common Shares21.93K shares | 8/28/2026 | M · Option Exercise | −21.93K | 5.10 | — | 779.33K |